Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07620522

Observational Study of RHINOSEDAL in Acute Nasal Obstruction

Sponsor: Laboratoires Elerte

View on ClinicalTrials.gov

Summary

This prospective, multicenter, national, observational, non-interventional post-market clinical follow-up study evaluates the performance and safety of RHINOSEDAL in children and adults presenting with acute nasal obstruction associated with common cold, allergic or non-allergic rhinitis, or rhinosinusitis. Patients prescribed RHINOSEDAL in routine care will be followed for 6 ±1 days using patient-reported outcome measures including the NOSE score.

Official title: Prospective Multicenter Before-After Study in Children and Adults Treated for Acute Nasal Obstruction With RHINOSEDAL

Key Details

Gender

All

Age Range

8 Years - Any

Study Type

OBSERVATIONAL

Enrollment

126

Start Date

2026-10-15

Completion Date

2027-12-31

Last Updated

2026-06-02

Healthy Volunteers

No

Interventions

DEVICE

RHINOSEDAL

RHINOSEDAL is a ready-to-use hypertonic nasal spray containing natural sea water, tamarind extract and mallow extract. It acts mechanically through osmotic decongestion and cleansing of the upper airways. It is used according to the instructions for use and physician prescription.

Locations (1)

Multiples facilities

Multiple Locations, France